reported a case of a patient with NSCLC whose pathological classification transformed into adenocarcinoma after ROS1 inhibitor resistance; this phenotypic change may be related to retinoblastoma‐1 (RB1) and TP53 inactivation.151. Here, ROS1 is linked to non-small cell lung carcinoma.